Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06778278 · ClinicalTrials.gov registry record · NA

Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans

A NA study of Suicidal Ideation and Mental Health, sponsored by RTI International.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06778278: Recruiting NA study of Suicidal Ideation and Mental Health, sponsored by RTI International.

NCT06778278 is a NA study of Suicidal Ideation and Mental Health that is actively recruiting participants, run by RTI International. The registered enrollment target is 40 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06778278, a NA study of Suicidal Ideation and Mental Health, is actively recruiting participants, sponsored by RTI International.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to develop and pilot a program designed to improve mental health outcomes and reduce suicide risk during the transition from military to civilian life. It is hypothesized that the Transition Health and Resilience through Valued Experiences (THRiVE) program, to be developed as part of this study, will meet participant recruitment, retention, and satisfaction benchmarks (primary outcomes) and show positive preliminary effects on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning outcomes (secondary outcomes). The specific aims of this study are to: 1. Develop a small-group, peer-led, cross-cutting prevention program for newly separated veterans (NSVs) called THRiVE and 2. Evaluate the feasibility, acceptability, and preliminary effects of the THRiVE program on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning outcomes. Up to 40 NSVs participating in this Stage 1 pilot study will complete validated self-report measures at baseline, immediately after completing the THRiVE program (post-THRiVE), and 3 months after completing the THRiVE program (follow-up). The duration of a participant's time in the study is anticipated to be 5 months.

Primary Outcome

The percentage of NSVs who are determined to be eligible based on their eligibility assessment and choose to enroll. It is anticipated that recruitment will begin May 2025 and enrollment of the final participant will be July 2026 (a recruitment/enrollment window of 14 months).

Interventions

  • BEHAVIORAL Transition Health and Resilience through Valued Experiences (THRiVE) Program

Study Locations (1)

North Carolina

  • RTI International - Durham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-07-30
Est. Completion 2026-10-31
Phase NA
RTI International

45 total trials

What NCT06778278 shows while recruiting

NCT06778278 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (85% lower).

The record links to 5 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Transition Health and Resilience through Valued Experiences (THRiVE) Program is the first listed.

NCT06778278 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06778278 about?

NCT06778278 is a clinical study titled "Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans". The objective of this study is to develop and pilot a program designed to improve mental health outcomes and reduce suicide risk during the transition from military to civilian life. It is hypothesized that the Transition Health and Resilience through Valued Experiences (THRiVE) program, to be devel...

What is the current status of trial NCT06778278?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-30. Estimated completion is 2026-10-31.

What conditions does trial NCT06778278 study?

This clinical trial studies the following conditions: Suicidal Ideation, Mental Health, Alcohol Misuse, Military Transition, Community Reintegration.

What interventions are being tested in trial NCT06778278?

The interventions under investigation include: Transition Health and Resilience through Valued Experiences (THRiVE) Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06778278?

This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06778278 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06778278's enrollment target sits among peer trials

40 73rd of 84 higher than 9 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06778278, the US trial registry maintained by the National Library of Medicine. NCT06778278 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.